Author

N. Kinoshita

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Ecology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:development & morphogenesis· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:ecology & biodiversity· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. Takagi· 1 shared C.-H. Sun· 1 shared C.-K. Ho· 1 shared C.-M. Liu· 1 shared G. W. Felton· 1 shared J. Gohda· 1 shared J.-A. Ou· 1 shared J.-i. Inoue· 1 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. Takagi

Author profile →

3 papers

Recent·Most cited

Cell BiologybioRxivPreprintOct 4, 2020

Force-dependent remodeling of cytoplasmic ZO-1 condensates contributes to cell-cell adhesion

N. Kinoshita, T. S. Yamamoto, N. Yasue…·N. Ueno

The paper shows that ZO-1 condensates in mouse embryos dissolve under mechanical stress, promoting cell-cell adhesion during development.

DOI 10.1101/2020.10.04.323436

mouseproteomics

𝕏 PostBluesky

EcologybioRxivMay 25, 2020

Changes in arthropod community but not plant quality benefit a specialist herbivore on plant under reduced water availability

P.-A. Lin, C.-M. Liu, J.-A. Ou…·G. W. Felton

The paper shows that reduced water availability benefits a specialist herbivore by increasing its larval survival, while negatively affecting most other herbivores through changes in plant quality.

DOI 10.1007/s00442-020-04845-z

plant (other)experimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 22, 2020

The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects

M. Yamamoto, M. Kiso, Y. Sakai-Tagawa…·J.-i. Inoue

This study shows nafamostat inhibits SARS-CoV-2 infection in vitro by blocking TMPRSS2-mediated fusion, with potency exceeding its blood concentration, suggesting it as a potential COVID-19 treatment.

DOI 10.1101/2020.04.22.054981

humanbulk RNA-seq

𝕏 PostBluesky